Dow Up 0.00% Nasdaq Up 0.09%

Acorda Therapeutics, Inc. (ACOR)

-NasdaqGS
36.45 Down 0.36(0.98%) Nov 28, 1:00PM EST
Prev Close:36.81
Open:36.80
Bid:29.70 x 400
Ask:N/A
1y Target Est:43.82
Beta:1.88
Earnings Date:Feb 11 - Feb 16 (Est.)
Day's Range:36.23 - 37.23
52wk Range:27.51 - 39.95
Volume:236,578
Avg Vol (3m):711,655
Market Cap:1.50B
P/E (ttm):66.39
EPS (ttm):0.55
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ACOR

Comparison

Symbol% ChgMkt Cap
ACORDown 0.98%1.50B
BIIBUp 0.91%72.66B
TEVAUp 0.30%48.71B

Key Statistics

Forward P/E (1 yr):158.48
P/S (ttm):4.03
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.47
Quarterly EPS Est (Dec-14) :0.06
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):1.74

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for multiple sclerosis (MS), spinal cord injury (SCI), and other disorders of the nervous system in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback